J&J, Imerys unit must pay $117 million in N.J. asbestos cancer case

NEW YORK (Reuters) – Johnson & Johnson and Imerys Talc America, a unit of Imerys SA, must pay $117 million in damages in a case involving a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.


Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *